Back to Rare Disease
This trial is complete. It is no longer accepting participants.

NCT00007059

NCT00007059
Completed Not Applicable

Who may be able to join

Who might be able to join this trial:

  • You have received a liver or kidney transplant (placed in the normal position in the body) and started taking a medication called mycophenolate mofetil (as part of your anti-rejection medication plan) within 5 days of your transplant
  • Your kidneys are producing at least 500 mL of urine per day, OR your kidney function blood test (creatinine) result is below 2.5 mg/dL
  • You are not pregnant
  • You test negative for HIV
  • You do not have an active infection (confirm with trial site for full definition)

Who may not be able to join:

  • You are currently taking bile acid sequestrant medications (a type of cholesterol or bowel medication)
  • You are taking mycophenolate mofetil as a "rescue" treatment (meaning it was added later to save a failing transplant, rather than from the start)
  • You are currently receiving albumin replacement therapy (a protein given through a drip)
  • You are pregnant
  • You have been assessed as unable to make your own medical decisions
  • You are currently a prisoner or on parole
  • You have an active infection, such as a high fever with an elevated white blood cell count, or repeated positive results from blood, urine, or sputum (mucus) tests showing the same type of infection

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

Trial details

Status
Completed
Phase
Not Applicable
Sponsor
National Center for Research Resources (NCRR)
Registry
clinicaltrials_gov
Start date
1 June 1998

Where this trial is recruiting

🇺🇸 United States

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

View original record on ClinicalTrials.gov